Royce & Associates’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Royce & Associates’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,900	Closed	-$195K	–	1333
2014 Q4	$195K	Hold	2,900	–	–	﹤0.01%	1194
2014 Q3	$156K	Hold	2,900	–	–	﹤0.01%	1294
2014 Q2	$129K	Hold	2,900	–	–	﹤0.01%	1322
2014 Q1	$101K	Hold	2,900	–	–	﹤0.01%	1337
2013 Q4	$84K	Hold	2,900	–	–	﹤0.01%	1366
2013 Q3	$85K	Hold	2,900	–	–	﹤0.01%	1368
2013 Q2	$67K	Buy	+2,900	New	+$73.2K	﹤0.01%	1360

Other funds holding CBPO

Warburg Pincus New York $187M AUM 34% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

EMR

Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Royce & Associates's CBPO Position: Q1 2015 in Review

Royce & Associates sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2015, closing a stake of 2,900 shares — an estimated $195K sold.

Royce & Associates first reported a position in CBPO in Q2 2013 and held it in 7 quarters. The position peaked at $195K in Q4 2014. 78 funds tracked by Wall St. Rank hold CBPO as of Q1 2015.

Royce & Associates reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2015 after selling out during the quarter.
Royce & Associates sold 2,900 China Biologic Products Holdings, Inc. shares in Q1 2015, an estimated $195K.
Royce & Associates first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 7 quarters.
Royce & Associates's China Biologic Products Holdings, Inc. position peaked at $195K in Q4 2014.
78 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.